chr22-37769332-A-G
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001039141.3(TRIOBP):āc.6806A>Gā(p.Asn2269Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00109 in 1,611,514 control chromosomes in the GnomAD database, including 15 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Consequence
NM_001039141.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TRIOBP | NM_001039141.3 | c.6806A>G | p.Asn2269Ser | missense_variant | 21/24 | ENST00000644935.1 | NP_001034230.1 | |
TRIOBP | NM_007032.5 | c.1667A>G | p.Asn556Ser | missense_variant | 11/14 | NP_008963.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TRIOBP | ENST00000644935.1 | c.6806A>G | p.Asn2269Ser | missense_variant | 21/24 | NM_001039141.3 | ENSP00000496394 | A2 | ||
TRIOBP | ENST00000403663.6 | c.1667A>G | p.Asn556Ser | missense_variant | 11/14 | 1 | ENSP00000386026 | P2 | ||
TRIOBP | ENST00000344404.10 | c.*6289A>G | 3_prime_UTR_variant, NMD_transcript_variant | 19/22 | 2 | ENSP00000340312 |
Frequencies
GnomAD3 genomes AF: 0.00573 AC: 872AN: 152252Hom.: 6 Cov.: 32
GnomAD3 exomes AF: 0.00134 AC: 325AN: 242666Hom.: 1 AF XY: 0.00102 AC XY: 135AN XY: 132620
GnomAD4 exome AF: 0.000609 AC: 888AN: 1459144Hom.: 9 Cov.: 34 AF XY: 0.000539 AC XY: 391AN XY: 725812
GnomAD4 genome AF: 0.00575 AC: 876AN: 152370Hom.: 6 Cov.: 32 AF XY: 0.00565 AC XY: 421AN XY: 74510
ClinVar
Submissions by phenotype
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Apr 30, 2012 | Asn2269Ser in Exon 21 of TRIOBP: This variant is not expected to have clinical s ignificance because it has been identified in 1.6% (54/3292) of African American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http ://evs.gs.washington.edu/EVS; dbSNP rs61729060). - |
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Feb 26, 2019 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at